Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
GNRH1 encodes gonadotropin-releasing hormone 1 (GnRH1), the decapeptide driving pituitary gonadotropin secretion. Pathogenic GNRH1 variants disrupt GnRH production or function, leading to idiopathic hypogonadotropic hypogonadism (MONDO:0018555), characterized by failed pubertal development, infertility, delayed puberty, and primary amenorrhea ([PMID:19535795]; [PMID:23936060]).
A homozygous frameshift variant, c.18dup (p.Leu7fs), was identified in two affected siblings from a consanguineous family with normosmic IHH; parents and an unaffected sibling were heterozygous carriers. In vitro expression showed absence of immunoreactive GnRH, confirming autosomal recessive LoF ([PMID:19535795]).
A recurrent missense change, c.91C>T (p.Arg31Cys), was found heterozygous in nine nCHH patients across four unrelated families, implicating a dominant mode of pathogenicity. All carriers displayed absent or delayed puberty and infertility, supporting a gain-of-function or dominant-negative mechanism ([PMID:23936060]).
Functional assays of p.Arg31Cys GnRH revealed dramatic reduction in receptor binding, MAPK signaling, inositol phosphate accumulation, intracellular calcium mobilization, and LHβ transcription, confirming peptide LoF ([PMID:23936060]).
The c.18dup and similar frameshift alleles abrogate the conserved decapeptide, resulting in complete loss of hormone production and failure to trigger downstream endocrine responses ([PMID:19535795]).
Genetic screening in additional IHH cohorts failed to detect GNRH1 coding mutations ([PMID:12788881]; [PMID:15546906]), indicating that GNRH1 defects account for ~1–2% of IHH cases. However, the combination of AR and AD pedigrees with robust functional concordance supports a strong gene–disease relationship.
Key take-home: GNRH1 LoF variants present a clinically actionable cause of idiopathic hypogonadotropic hypogonadism, warranting inclusion in diagnostic gene panels to guide early GnRH therapy and fertility management.
Gene–Disease AssociationStrong11 probands in five families with both homozygous LoF and heterozygous R31C variants showing segregation and consistent phenotype Genetic EvidenceStrong2 siblings with homozygous frameshift variants (AR) ([PMID:19535795]) and 9 heterozygous R31C carriers in 4 families (AD) ([PMID:23936060]) Functional EvidenceModerateIn vitro studies demonstrate absence of GnRH production for frameshifts ([PMID:19535795]) and impaired receptor activation for p.Arg31Cys ([PMID:23936060]) |